APLS is expanding SYFOVRE's potential with a phase 2 study combining it with siRNA APLS-3007, aiming to enhance efficacy in ...

Huntington's disease is a fatal, hereditary neurological disorder mostly striking people between the ages of 30 and 50.

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

The investment from Brown parents Giammaria and Sabrina Giuliani will support scholars seeking to unlock the potential of RNA ...

Brown’s Giuliani RNA Center and the Rhode Island Life Science Hub co-hosted a symposium focused on how scientists can work ...

Scientists are exploring how RNA might have jump-started life four billion years ago and how it's now advancing drug ...

Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one ...

IGF2BP3 links cancer metabolism and RNA control, offering a potential new therapeutic target for blocking leukemia cell growth.

Coming into the GI Pennsylvania Derby, Puca (Big Brown) may already have been the most valuable broodmare on the planet. But in the 1:48.03 it took to contest that race, she became worth even more. Ba ...